Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Coherus signs in-licensing agreement for Avastin biosimilar

pharmaceutical-technologyJanuary 15, 2020

Tag: Coherus , Avastin , Innovent , IBI305

PharmaSources Customer Service